# Dexmedetomidine Cycling and Sleep in the Pediatric ICU

> **NCT05003102** · PHASE4 · WITHDRAWN · sponsor: **Vanderbilt University Medical Center**

## Conditions studied

- Critical Illness
- Sedation Complication
- Delirium

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride - Cycling
- **DRUG:** Fentanyl - PICU Standard
- **DRUG:** Dexmedetomidine Hydrochloride - PICU Standard

## Key facts

- **NCT ID:** NCT05003102
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-02-20
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No enrollment, IRB closed
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05003102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05003102, "Dexmedetomidine Cycling and Sleep in the Pediatric ICU". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05003102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*